Project Details
Description
CHIMERNA aims to develop and
validate a Hydrogel Immune Modulating Therapy (HIT) that can be injected subcutaneously and is a hub for in situ immune cell modification.
validate a Hydrogel Immune Modulating Therapy (HIT) that can be injected subcutaneously and is a hub for in situ immune cell modification.
Acronym | FWOEUAR2 |
---|---|
Status | Active |
Effective start/end date | 1/01/25 → 31/12/27 |
Keywords
- immune therapy
Flemish discipline codes in use since 2023
- Cancer therapy